|
RCL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.95034000000094E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.241000E-04 |
| Normal-vs-Stage2 |
4.536500E-03 |
| Normal-vs-Stage3 |
8.640300E-02 |
| Normal-vs-Stage4 |
5.727800E-02 |
| Stage1-vs-Stage2 |
7.478600E-01 |
| Stage1-vs-Stage3 |
9.023600E-01 |
| Stage1-vs-Stage4 |
6.587400E-01 |
| Stage2-vs-Stage3 |
8.969400E-01 |
| Stage2-vs-Stage4 |
8.201600E-01 |
| Stage3-vs-Stage4 |
8.202800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64579999994974E-06 |
| Normal-vs-AfricanAmerican |
1.564570E-01 |
| Normal-vs-Asian |
1.357010E-01 |
| Caucasian-vs-AfricanAmerican |
4.882300E-02 |
| Caucasian-vs-Asian |
7.816600E-01 |
| AfricanAmerican-vs-Asian |
3.108200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.1529999973462E-08 |
| Normal-vs-Female |
5.222600E-01 |
| Male-vs-Female |
8.597500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.125960E-02 |
| Normal-vs-Extreme_Weight |
5.63099999999483E-05 |
| Normal-vs-Obese |
4.030000E-02 |
| Normal-vs-Extreme_Obese |
1.004010E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.020600E-01 |
| Normal_Weight-vs-Obese |
6.925200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.715000E-01 |
| Extreme_Weight-vs-Obese |
3.949600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.683400E-01 |
| Obese-vs-Extreme_Obese |
7.134200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.827200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.459700E-03 |
| Normal-vs-Age(61-80Yrs) |
7.31580000024046E-07 |
| Normal-vs-Age(81-100Yrs) |
3.861300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.007200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.839010E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.115020E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.103360E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.298200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.097400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.434400E-04 |
| Normal-VS-Type2 PRCC |
2.24799999948289E-07 |
| Normal-VS-KIRP CIMP |
1.925590E-01 |
| Normal-VS-Unclassified PRCC |
9.079300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.637580E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.499900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.769800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.385700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.225600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.029800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.35619999961112E-07 |
| Normal-vs-N1 |
1.719680E-02 |
| Normal-vs-N2 |
6.45860000036969E-07 |
| N0-vs-N1 |
6.882800E-01 |
| N0-vs-N2 |
1.636010E-01 |
| N1-vs-N2 |
2.529200E-01 |
|
|
